Results
|
6061.
|
|
|
6062.
|
|
|
6063.
|
|
|
6064.
|
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study. [electronic resource] by
- Aerts, J G
- Codrington, H
- Lankheet, N A G
- Burgers, S
- Biesma, B
- Dingemans, A-M C
- Vincent, A D
- Dalesio, O
- Groen, H J M
- Smit, E F
Producer: 20140602
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
6065.
|
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. [electronic resource] by
- Goldkorn, Amir
- Ely, Benjamin
- Quinn, David I
- Tangen, Catherine M
- Fink, Louis M
- Xu, Tong
- Twardowski, Przemyslaw
- Van Veldhuizen, Peter J
- Agarwal, Neeraj
- Carducci, Michael A
- Monk, J Paul
- Datar, Ram H
- Garzotto, Mark
- Mack, Philip C
- Lara, Primo
- Higano, Celestia S
- Hussain, Maha
- Thompson, Ian Murchie
- Cote, Richard J
- Vogelzang, Nicholas J
Producer: 20140605
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|
|
6066.
|
|
|
6067.
|
|
|
6068.
|
|
|
6069.
|
|
|
6070.
|
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. [electronic resource] by
- Pernot, Simon
- Mitry, Emmanuel
- Samalin, Emmanuelle
- Dahan, Laetitia
- Dalban, Cécile
- Ychou, Marc
- Seitz, Jean-François
- Turki, Hajer
- Mazard, Thibault
- Zaanan, Aziz
- Lepère, Céline
- Vaillant, Jean-Nicolas
- Landi, Bruno
- Rougier, Philippe
- Taieb, Julien
Producer: 20141216
In:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 17
Availability: No items available.
|
|
6071.
|
A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study). [electronic resource] by
- Ueda, Yutaka
- Miyatake, Takashi
- Nagamatsu, Masaaki
- Yamasaki, Masato
- Nishio, Yukihiro
- Yoshino, Kiyoshi
- Fujita, Masami
- Tsutsui, Tateki
- Enomoto, Takayuki
- Kimura, Tadashi
Producer: 20140602
In:
European journal of obstetrics, gynecology, and reproductive biology vol. 170
Availability: No items available.
|
|
6072.
|
|
|
6073.
|
|
|
6074.
|
|
|
6075.
|
|
|
6076.
|
An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. [electronic resource] by
- Xu, He-Lin
- Mao, Kai-Li
- Lu, Cui-Tao
- Fan, Zi-Liang
- Yang, Jing-Jing
- Xu, Jie
- Chen, Pian-Pian
- ZhuGe, De-Li
- Shen, Bi-Xin
- Jin, Bing-Hui
- Xiao, Jian
- Zhao, Ying-Zheng
Producer: 20171207
In:
Biomaterials vol. 107
Availability: No items available.
|
|
6077.
|
|
|
6078.
|
|
|
6079.
|
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. [electronic resource] by
- Büyükkaramikli, Nasuh C
- Blommestein, Hedwig M
- Riemsma, Rob
- Armstrong, Nigel
- Clay, Fiona J
- Ross, Janine
- Worthy, Gill
- Severens, Johan
- Kleijnen, Jos
- Al, Maiwenn J
Producer: 20180702
In:
PharmacoEconomics vol. 35
Availability: No items available.
|
|
6080.
|
|